Infection, Coronavirus
9
1
1
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
11%
1 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (9)
Assessment of Fit of Novel N95 Style Transparent Face Masks
Xofluza-Wearables Feasibility-Study
Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?
Incidence of Infection and Mortality by COVID-19 in Specialists
Host-pathogen Interactions During SARS-CoV-2 Infection
Evaluation of the Effectiveness of Therapy for Patients With Covid-19 Using Food Supplements Viusid + Asbrip
Use of Angiotensin-(1-7) in COVID-19
COVID-19 Infections and Mortality in Long-term Care Facilities During the First Wave
COVID 19 Viral Clearance Among the Infected Healthcare Workers In Assiut University Hospitals